This article discusses dangers of tampon use; under researched and lack of information available from companies; chemicals, toxic shock syndrome; government inaction; alternatives to tampons.
British Columbia Centre of Excellence for Women's Health (BCCEWH)
Media Type:
Paper
Author:
Ann Pederson
Aleina Tweed
Discusses the challenges of understanding the effects of breast implants and breast implant surgery. Proposes the establishment of a breast implant registry to collect information about this medical device and its use in Canada.
Examines Health Canada's consultation to change the status of the emergency contraception drug, more commonly known as the Morning After pill and marketed in Canada as Plan B, to non-prescription status. States the CWHN's position.
Works to take an integrated approach to the management of the risks and benefits to health related to health products and food by: minimizing health risk factors to Canadians while maximizing the safety provided by the regulatory system for health products and food; and, promoting conditions that enable Canadians to make healthy choices and providing information so that they can make informed decisions about their health.
Forms an organization that provides unbiased, reliable information about health technologies, focusing on evaluations of clinical effectiveness and cost-effectiveness.
Discusses how many safety regulations governing what types of drugs and medical devices can be sold in Canada provide a backdrop to many key concerns raised by women's health groups.
Presents the recommendations of the Office of Natural Health Products Transition Team on the administrative and regulatory framework for the regulation of natural health products.
Reports on the open consultation meetings on the proposed regulatory system that will provide for natural health product labelling and licensing, site licensing, good manufacturing practices, and reporting on adverse events, as well as on a proposed approach for regulating vitamins and minerals.
